Garcia Sanchez Juan Jose, Barraclough Katherine A, Cases Aleix, Pecoits-Filho Roberto, Germond-Duret Celine, Zoccali Carmine, Embleton Nina, Wright Antony, Hubbert Luke, Nicholson Lindsay, Barone Salvatore, Budgen Nigel, Cabrera Claudia, Selvarajah Viknesh, Eckelman Matthew J
Global Market Access and Pricing, AstraZeneca, C/d'Estruc, 9, 08002, Barcelona, Spain.
Department of Nephrology, Royal Melbourne Hospital, Melbourne, Australia.
Adv Ther. 2025 Jan;42(1):348-361. doi: 10.1007/s12325-024-03039-w. Epub 2024 Nov 14.
While the economic and clinical burden of chronic diseases are well documented, their environmental impact remains poorly understood. We developed a framework to estimate the environmental impact of a disease care pathway using chronic kidney disease (CKD) as an example.
A life cycle assessment framework was developed for the CKD care pathway and validated by experts. Life cycle stages were characterised for resource utilisation based on a literature review and ecoinvent database inputs, in ten countries. The ReCiPe impact assessment method was used to calculate impacts across multiple environmental dimensions.
At CKD stage 5, kidney replacement therapies (KRT) have highest impact; emissions ranged between 3.5 and 43.9 kg carbon dioxide equivalents (COe) per session depending on dialysis modality, and 336-2022 kg COe for kidney transplant surgery, depending on donor type. Hospitalisations have a substantial environmental impact: a 1-day intensive care stay had highest impact (66.4-143.6 kg COe), followed by a 1-day hospital stay (28.8-63.9 kg COe) and an 8-h emergency room visit (14.4-27.5 kg COe). Patient transport to and from healthcare sites was a key driver of environmental impact for all life cycle stages, representing up to 99.5% of total COe emissions.
Full care pathways should be analysed alongside specific healthcare processes. Application of this framework enables quantification of the environmental benefits of preventative medicine and effective management of chronic diseases. For CKD, early diagnosis, and proactive management to reduce the need for KRT and hospitalisations could improve patient outcomes and reduce environmental burden.
虽然慢性病的经济和临床负担已有充分记录,但其对环境的影响仍知之甚少。我们开发了一个框架,以慢性肾脏病(CKD)为例来估算疾病护理路径对环境的影响。
为CKD护理路径开发了一个生命周期评估框架,并由专家进行了验证。基于文献综述和ecoinvent数据库输入,对十个国家的生命周期阶段进行了资源利用特征分析。采用ReCiPe影响评估方法来计算多个环境维度的影响。
在CKD 5期,肾脏替代疗法(KRT)的影响最大;根据透析方式,每次治疗的排放量在3.5至43.9千克二氧化碳当量(COe)之间,而肾移植手术的排放量在336至2022千克COe之间,具体取决于供体类型。住院治疗对环境有重大影响:1天的重症监护住院影响最大(66.4至143.6千克COe),其次是1天的住院(28.8至63.9千克COe)和8小时的急诊室就诊(14.4至27.5千克COe)。患者往返医疗机构的交通是所有生命周期阶段环境影响的关键驱动因素,占总COe排放量的99.5%。
应结合特定的医疗保健流程对完整的护理路径进行分析。应用该框架能够量化预防医学的环境效益以及慢性病的有效管理。对于CKD,早期诊断和积极管理以减少对KRT和住院治疗的需求,可以改善患者预后并减轻环境负担。